AryoGen

AryoGen Biopharma is a biopharmaceutical company specializing in manufacturing Therapeutic Monoclonal antibodies and some other recombinant proteins.

History
A group of experts in a well experienced Biopharmaceutical company formed a totally new entity in 2010 with the name of AryoGen Biopharma.

Products
AryoGen's products include Blood Coagulation factor VII with the name of AryoSeven which is a biosimilar form of Novoseven, Altebrel with the generic name of Etanercept and original trade name of Enbrel, Zitux with the generic name of Rituximab and original trade name of Rituxan, Hebreastin with the generic name of trastuzumab and original name of Herceptin, Arvestin with the generic name of bevacizumab and original trade name of Avestin. AryoSeven is now approved by Iranian food and drug organisation and from Aug 2012 is in the market.